Skip to main content
. 2024 Jul 9;25(14):7530. doi: 10.3390/ijms25147530

Table 3.

Comparison of cancer incidence and mortality by cancer type between global and Republic of Korea, 2022.

1 ASR Cancer Incidence per
100,000 Population
ASR Cancer Mortality per
100,000 Population
Cancer Type/Site Global Republic of Korea Global Republic of Korea
Bladder 5.58 4.1 1.82 1.1
Brain, CNS 3.47 3.0 2.59 1.5
Breast 46.82 33.1 12.65 2.9
Cervix uteri 14.12 3.7 7.08 0.7
Colorectum 18.35 26.4 8.05 6.6
Corpus uteri 8.37 4.2 1.72 0.4
Esophagus 4.97 2.4 4.26 1.0
Gallbladder 1.15 6.6 0.83 3.9
Kidney 4.42 7.4 1.46 0.9
Leukemia 5.26 5.7 3.093 1.9
Lip and oral cavity 4.00 4.3 1.92 1.1
2 Liver 8.57 14.3 7.37 7.7
3 Lung 23.62 27.6 16.76 13.4
Multiple myeloma 1.79 1.8 1.11 0.7
Non-Hodgkin’s lymphoma 5.57 6.7 2.38 1.8
Ovary 6.65 3.7 3.97 1.3
Pancreas 4.69 7.7 4.21 5.6
Prostate 29.42 18.4 7.27 1.4
Stomach 9.18 24.0 6.09 4.1
Thyroid 9.12 47.6 0.44 0.2

1 ASR: age-standardized rates. 2 includes the liver and intrahepatic bile duct, 3 includes the lung and bronchus. Age-Standardized Rate (World) per 100,000, Incidence and Mortality, Both sexes, in 2022, Cancer Today, IARC.—https://gco.iarc.who.int (accessed on 7 June 2024).Global data were adapted from [204] with permission from Copyright © International Agency for Research on Cancer. Republic of Korea data were adapted from [205] (CC By 4.0) with permission from Copyright © 2022 Korean Cancer Association.